Mukri, M.N.A., Kong, W.-Y., Mustafar, R., Shaharir, S.S., Shah, S.A., Abdul Gafor, A.H., Mohd, R., Abdul Cader, R. and Kamaruzaman, L. 2018. Role of febuxostat in retarding progression of diabetic kidney disease with asymptomatic hyperuricemia: A 6-months open-label, randomized controlled trial. EXCLI Journal. 17, (Jun. 2018), 563–575. DOI:https://doi.org/10.17179/excli2018-1256.